MARATTO

article · Scholars Journal of Medical Case Reports

Visual Disturbances Secondary to the Use of Lamotrigine in a Patient Suffering from Bipolar Depression: Case Report

2024Open accessMohamed I University

Abstract

Lamotrigine is a second-generation anticonvulsant approved for the treatment of epilepsy. Like other antiepileptics, lamotrigine is also used off-label in bipolar disorders as a mood stabiliser. We describe the case of a patient suffering from bipolar disorder type 2 who developed ocular toxicity following the use of lamotrigine in the management of his mental illness. The vast majority of these visual side effects are non-serious, rare, of mild to moderate intensity. And they appear to be reversible once treatment is stopped.

Research topics

  • Pharmacological Effects and Toxicity Studies
  • Electroconvulsive Therapy Studies
  • Pharmacovigilance and Adverse Drug Reactions

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.36347/sjmcr.2024.v12i04.037

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.